Xiamen Amoytop Biotech Co., Ltd. (688278.SS) — Stock Score Summary

Xiamen Amoytop Biotech Co., Ltd. (688278.SS) has a MoatMap StockRank of 65/100 based on Quality (84/100), Value (30/100), and Momentum (36/100) factor scores. The current signal is BUY. Xiamen Amoytop Biotech is a Chinese biopharmaceutical company focused on recombinant proteins. While it has high quality metrics, it is a drug developer rather than a CDMO, meaning it does not benefit from the CDMO pricing power cycle theme.

Xiamen Amoytop Biotech is a biopharmaceutical company specializing in recombinant protein drugs, with a focus on long-acting interferons for chronic hepatitis B. The company's competitive moat is anchored by its proprietary PEGylation technology platform and strong clinical adoption of its flagship product, Pegbin. It is a leading niche player in China's viral hepatitis treatment market.

Key Financial Metrics

Price$8.67
Market Cap$3.4B
P/E (TTM)22.26
P/E (Forward)12.93
Price/Book6.18
Return on Equity31.8%
Return on Invested Capital32.1%
Debt/Equity5.15
Gross Margin92.2%
Operating Margin24.6%
Revenue Growth18.5%
Dividend Yield1.1%
Free Cash Flow$6M

Xiamen Amoytop Biotech Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Xiamen Amoytop Biotech Co., Ltd.’s (688278.SS) StockRank?
MoatMap’s StockRank for Xiamen Amoytop Biotech Co., Ltd. (688278.SS) is 65/100, with a Buy signal. It is a composite of Quality (84), Value (30), and Momentum (36) factor ranks across MoatMap’s 19,000+ stock universe.
Does Xiamen Amoytop Biotech Co., Ltd. have an economic moat?
Xiamen Amoytop Biotech Co., Ltd. (688278.SS) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Xiamen Amoytop Biotech Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Xiamen Amoytop Biotech Co., Ltd. (688278.SS) is Buy, based on a StockRank of 65/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Xiamen Amoytop Biotech Co., Ltd. in?
Xiamen Amoytop Biotech Co., Ltd. (688278.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688278.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock